Fenofibrate 51655-0856-52
- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 13, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA213864
Need to source Fenofibrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fenofibrate | 160 mg/1 |
Drug Class
Peroxisome Proliferator Receptor alpha Agonist [EPC]Peroxisome Proliferator Receptor alpha Agonist [EPC]
Selected Package
51655-0856-52Selected30 TABLET in 1 BOTTLE, PLASTIC (51655-856-52)